Advaxis, Inc. – “Pediatric Osteosarcoma: The First Indication in the ADXS-cHER2 Franchise”

[Accesswire] – PRINCETON, NJ / ACCESSWIRE / May 7, 2014 / Advaxis, Inc. (NASDAQ: ADXS) today published a new blog post on The Chairman’s Blog, written by the Company’s CEO, Mr. Daniel J. O’Connor. TheChairmansBlog.com … more

View todays social media effects on ADXS

View the latest stocks trending across Twitter. Click to view dashboard

See who Advaxis is hiring next, click here to view